Covered recipient · General Payments record
LAURA MARIE DE LA TORRE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,067.41
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $195.47 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $38.69 | 2 |
| Axsome Therapeutics, Inc. | $34.84 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.68 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.04 | 1 |
| ABBVIE INC. | $21.04 | 1 |
| Janssen Pharmaceuticals, Inc | $20.74 | 1 |
| Teva Pharmaceuticals USA, Inc. | $19.32 | 1 |
| Neurocrine BioSciences, Inc. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.04 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107000195 | CMS |
| Alexion Pharmaceuticals, Inc. | $22.04 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093940979 | CMS |
| Axsome Therapeutics, Inc. | $34.84 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148382724 | CMS |
| Janssen Pharmaceuticals, Inc | $20.74 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078026492 | CMS |
| Lundbeck LLC | $23.11 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146012319 | CMS |
| Lundbeck LLC | $15.58 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146012321 | CMS |
| Neurocrine Biosciences, Inc. | $14.12 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151007175 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.68 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119056560 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.32 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151632821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.